Ophthalmic Devices Market Is Expected To Reach Revenue Of USD 120.3 Bn By 2033, At 5.1% CAGR: Dimension Market Research.
01 oct. 2024 14h01 HE
|
Dimension Market Research
New York, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Ophthalmic Devices Market is projected to reach USD 76.9 billion in 2024 and is expected to grow to USD 120.3 billion by...
Evolving Landscape of Open-Angle Glaucoma Pipeline Therapies in 2024
25 sept. 2024 04h12 HE
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Open-Angle Glaucoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive analytical report has been...
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
17 juil. 2024 16h14 HE
|
NurExone Biologic Inc
TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
28 juin 2024 16h04 HE
|
NurExone Biologic Inc
Prestigious Eye Institute Exploring New Indication for NurExone’s ExoPTEN
Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 Billion Opportunity by 2034 with Regional and Country-Level Data for Types, Drugs, Treatments, and End-users
12 mars 2024 12h13 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region" report has been added to ...
Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to Reach USD 9.1 billion by 2031 | Transparency Market Research, Inc.
19 déc. 2023 03h41 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The glaucoma treatment market was valued at US$ 6.3 billion in 2022. A CAGR of 4.3% is...
Ocular Hypertension Pipeline Research Report 2023: Comprehensive Insights About 70+ Companies and 75+ Pipeline Drugs
24 nov. 2023 05h43 HE
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "Ocular Hypertension - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ocular Hypertension - Pipeline...
Prostaglandin Analogs Dominating Global Glaucoma Treatment Market - Ongoing Technological Advancements Boost Growth
03 août 2023 07h48 HE
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Glaucoma Treatment Market by Indication, Type, Sales Channel - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering. ...
Glaucoma Treatment Market Report (2023 to 2031) – Alcon, Merck & Co., Inc., Novartis AG, Pfizer Inc., and AbbVie Inc.
13 juin 2023 09h30 HE
|
Growth Plus Reports
Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glaucoma treatment market was conducted by Growth Plus Reports in 2022 and is valued at US$ 5.89 billion....
Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
20 sept. 2022 05h18 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...